Predicting Mortality after Autologous Transplant: Development of a Novel Risk Score-Reference-Cited by-同舟云学术

Predicting Mortality after Autologous Transplant: Development of a Novel Risk Score

Published:2020-10 Issue:10 Volume:26 Page:1828-1832
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Berro Mariano,Chhabra Saurabh,Piñana José Luis,Arbelbide Jorge,Rivas Maria M.,Basquiera Ana Lisa,Vitriu Adriana,Requejo Alejandro,Milovic Vera,Yantorno Sebastian,Bentolila Gonzalo,Garcia Juan Jose,Castro Martin,Palmer Silvina,Saslavsky Martin,Duarte Patricio,Cerutti Amalia,Jarchum Gustavo,Tisi Baña Matias,Thapa Bicky,Solano Carlos,Sureda Anna,Rovira Montserrat,Shaw Bronwen E,Kusminsky Gustavo

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference30 articles.

1. Indications for haematopoietic stem cell transplantation for haematological disease, solid tumours and immune disorders< current practice in Europe;Duarte;Bone Marrow Transplant,2019

2. Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation;Majhail;Biol Blood Marrow Transplant,2015

3. Allogeneic compared to autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMA AML-10 trial;Suciu;Blood,2003

4. The hematopoietic stem cell transplant comorbidity index (HCT.CI) can predict for 30-day readmission following autologous stem cell transplant for lymphoma and multiple myeloma;Jaglowski;Biol Blood Marrow Transplant,2014

5. The international prognostic factors project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation;Bierman;Ann Oncol,2002

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of the GATMO score in predicting non‐relapse mortality following hematopoietic cell transplant in multiple myeloma patients;European Journal of Haematology;2023-10-07

2. Third BNT162b2 mRNA SARS-CoV-2 Vaccine Dose Significantly Enhances Immunogenicity in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation;Vaccines;2023-03-31

3. Cost-Effectiveness Analysis of Frontline Polatuzumab-Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone and/or Second-Line Chimeric Antigen Receptor T-Cell Therapy Versus Standard of Care for Treatment of Patients With Intermediate- to High-Risk Diffuse Large B-Cell Lymphoma;Journal of Clinical Oncology;2023-03-10

4. Retracted: “Factors Affecting Time to Engraftment During Autologous Stem Cell Transplantation in Patients With Multiple Myeloma”;Plasmatology;2023-01

5. Cryopreserved versus non-cryopreserved stem cell autografts in multiple myeloma a restrospective cohort study;Bone Marrow Transplantation;2022-05-30